Immuneering Corporation <IMRX.O>: H.C. Wainwright initiates coverage with buy rating
IMRX•Related News
Unity Q2 FY26 GAAP net loss narrows to $23 million; revenue rises 24% to $546 million
U•
Harrow to buy dry eye nasal spray Tyrvaya from Viatris for up to $100 million
HROW•
Roivant Q1 FY27 net loss widens to $290.61 million; revenue slips to $1.44 million
ROIV•
AMETEK <AME.N>: Truist Securities raises target price to $316 from $303
AME•
Via posts transcript of Q2 2026 earnings call
VIA•